John Oyler shares an update on BeiGene during San Francisco Healthcare Week
John Oyler discusses BeiGene's BTK, PD1, and other programs, and talks about the company's cost structure. Plus, the status of drug reimbursement in China.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
.png){kind=logo}
The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants
bottom of page
Comentarios